BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 9226332)

  • 1. Rapid assay of intrinsic radiosensitivity based on apoptosis in human CD4 and CD8 T-lymphocytes.
    Ozsahin M; Ozsahin H; Shi Y; Larsson B; Würgler FE; Crompton NE
    Int J Radiat Oncol Biol Phys; 1997 May; 38(2):429-40. PubMed ID: 9226332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional response to ionizing radiation in lymphocyte subsets.
    Mori M; Benotmane MA; Tirone I; Hooghe-Peters EL; Desaintes C
    Cell Mol Life Sci; 2005 Jul; 62(13):1489-501. PubMed ID: 15971001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ionizing radiation on gene expression in CD4+ T lymphocytes and in Jurkat cells: unraveling novel pathways in radiation response.
    Mori M; Benotmane MA; Vanhove D; van Hummelen P; Hooghe-Peters EL; Desaintes C
    Cell Mol Life Sci; 2004 Aug; 61(15):1955-64. PubMed ID: 15341025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative proteomic analysis reveals AK2 as potential biomarker for late normal tissue radiotoxicity.
    Lacombe J; Brengues M; Mangé A; Bourgier C; Gourgou S; Pèlegrin A; Ozsahin M; Solassol J; Azria D
    Radiat Oncol; 2019 Aug; 14(1):142. PubMed ID: 31399108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vertebral body irradiation during chemoradiation therapy for esophageal cancer contributes to acute bone marrow toxicity.
    Zhang A; Deek MP; Kim S; Sayan M; Grann A; Wagman RT; Malhotra U; Hathout L; Biswal N; Zhang Y; Langenfeld J; Kennedy T; August DA; Jabbour SK
    J Gastrointest Oncol; 2019 Jun; 10(3):513-522. PubMed ID: 31183202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort study.
    Mirjolet C; Merlin JL; Truc G; Noël G; Thariat J; Domont J; Sargos P; Renard-Oldrini S; Ray-Coquard I; Liem X; Chevreau C; Lagrange JL; Mahé MA; Collin F; Bonnetain F; Bertaut A; Maingon P
    EBioMedicine; 2019 Mar; 41():420-426. PubMed ID: 30827931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-patient and inter-patient comparisons of DNA damage response biomarkers in Nasopharynx Cancer (NPC): analysis of NCC0901 randomised controlled trial of induction chemotherapy in locally advanced NPC.
    Chua KLM; Yeo ELL; Shihabudeen WA; Tan SH; Shwe TT; Ong EHW; Lam PYP; Soo KC; Soong YL; Fong KW; Tan TWK; Wee JTS; Chua MLK
    BMC Cancer; 2018 Nov; 18(1):1095. PubMed ID: 30419858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalizing Breast Cancer Irradiation Using Biology: From Bench to the Accelerator.
    Azria D; Brengues M; Gourgou S; Bourgier C
    Front Oncol; 2018; 8():83. PubMed ID: 29675397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era.
    Azria D; Lapierre A; Gourgou S; De Ruysscher D; Colinge J; Lambin P; Brengues M; Ward T; Bentzen SM; Thierens H; Rancati T; Talbot CJ; Vega A; Kerns SL; Andreassen CN; Chang-Claude J; West CML; Gill CM; Rosenstein BS
    Front Oncol; 2017; 7():83. PubMed ID: 28497027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex Vivo Apoptosis in CD8+ Lymphocytes Predicts Rectal Cancer Patient Outcome.
    Winkler S; Hoppe P; Haderlein M; Hecht M; Fietkau R; Distel LV
    Gastroenterol Res Pract; 2016; 2016():5076542. PubMed ID: 27340400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiogenomics: A systems biology approach to understanding genetic risk factors for radiotherapy toxicity?
    Herskind C; Talbot CJ; Kerns SL; Veldwijk MR; Rosenstein BS; West CM
    Cancer Lett; 2016 Nov; 382(1):95-109. PubMed ID: 26944314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New biological markers in the decision of treatment of head and neck cancer patients.
    Valenciano A; Henríquez-Hernández LA; Lloret M; Pinar B; Lara PC
    Clin Transl Oncol; 2014 Oct; 16(10):849-58. PubMed ID: 24981589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radio-induced apoptosis of peripheral blood CD8 T lymphocytes is a novel prognostic factor for survival in cervical carcinoma patients.
    Ordoñez R; Henríquez-Hernández LA; Federico M; Valenciano A; Pinar B; Lloret M; Bordón E; Rodríguez-Gallego C; Lara PC
    Strahlenther Onkol; 2014 Feb; 190(2):210-6. PubMed ID: 24362501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biomarkers in the decision of treatment of cervical carcinoma patients.
    Valenciano A; Henríquez-Hernández LA; Lloret M; Pinar B; Lara PC
    Clin Transl Oncol; 2013 Aug; 15(8):587-92. PubMed ID: 23430538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined low initial DNA damage and high radiation-induced apoptosis confers clinical resistance to long-term toxicity in breast cancer patients treated with high-dose radiotherapy.
    Henríquez-Hernández LA; Carmona-Vigo R; Pinar B; Bordón E; Lloret M; Núñez MI; Rodríguez-Gallego C; Lara PC
    Radiat Oncol; 2011 Jun; 6():60. PubMed ID: 21645372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of clinical toxicity in locally advanced head and neck cancer patients by radio-induced apoptosis in peripheral blood lymphocytes (PBLs).
    Bordón E; Henríquez-Hernández LA; Lara PC; Ruíz A; Pinar B; Rodríguez-Gallego C; Lloret M
    Radiat Oncol; 2010 Jan; 5():4. PubMed ID: 20109191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidisciplinary approach of early breast cancer: the biology applied to radiation oncology.
    Bourgier C; Ozsahin M; Azria D
    Radiat Oncol; 2010 Jan; 5():2. PubMed ID: 20074364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of clinical toxicity in localized cervical carcinoma by radio-induced apoptosis study in peripheral blood lymphocytes (PBLs).
    Bordón E; Henríquez Hernández LA; Lara PC; Pinar B; Fontes F; Rodríguez Gallego C; Lloret M
    Radiat Oncol; 2009 Nov; 4():58. PubMed ID: 19941649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy.
    Azria D; Ozsahin M; Kramar A; Peters S; Atencio DP; Crompton NE; Mornex F; Pèlegrin A; Dubois JB; Mirimanoff RO; Rosenstein BS
    Clin Cancer Res; 2008 Oct; 14(19):6284-8. PubMed ID: 18829510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual radiosensitivity and its relevance to health physics.
    Schnarr K; Dayes I; Sathya J; Boreham D
    Dose Response; 2007 Nov; 5(4):333-48. PubMed ID: 18648561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.